Found: 37
Select item for more details and to access through your institution.
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
- Published in:
- Clinical Breast Cancer, 2024, v. 24, n. 5, p. 431, doi. 10.1016/j.clbc.2024.02.013
- By:
- Publication type:
- Article
Expression of wild-type estrogen receptor β protein in human breast cancer: Specific correlation with HER2/ neu overexpression.
- Published in:
- Pathology International, 2006, v. 56, n. 8, p. 423, doi. 10.1111/j.1440-1827.2006.01983.x
- By:
- Publication type:
- Article
A multicenter Phase II study evaluating the efficacy, safety and pharmacokinetics of trastuzumab emtansine in Japanese patients with heavily pretreated HER2-positive locally recurrent or metastatic breast cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 5, p. 407, doi. 10.1093/jjco/hyw013
- By:
- Publication type:
- Article
Induction of SGK1 via glucocorticoid-influenced clinical outcome of triple-negative breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 200, n. 3, p. 323, doi. 10.1007/s10549-023-06990-4
- By:
- Publication type:
- Article
Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 180, n. 1, p. 97, doi. 10.1007/s10549-020-05523-7
- By:
- Publication type:
- Article
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 173, n. 2, p. 275, doi. 10.1007/s10549-018-4985-6
- By:
- Publication type:
- Article
Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 4, p. 1137, doi. 10.1007/s00520-014-2597-1
- By:
- Publication type:
- Article
ASO Author Reflections: Patients' Satisfaction After Breast Conserving Surgery Using the Suture Scaffold Technique.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 6, p. 3836, doi. 10.1245/s10434-022-11513-4
- By:
- Publication type:
- Article
Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 6, p. 3829, doi. 10.1245/s10434-022-11446-y
- By:
- Publication type:
- Article
Aromatase inhibitor-induced bone mineral loss and its prevention by bisphosphonate administration in postmenopausal breast cancer patients.
- Published in:
- Journal of Obstetrics & Gynaecology Research, 2007, v. 33, n. 5, p. 696, doi. 10.1111/j.1447-0756.2007.00634.x
- By:
- Publication type:
- Article
Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 262, doi. 10.1007/s10147-018-1359-3
- By:
- Publication type:
- Article
Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 6, p. 1102, doi. 10.1007/s10147-015-0832-5
- By:
- Publication type:
- Article
A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study).
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 4, p. 598, doi. 10.1007/s10147-012-0437-1
- By:
- Publication type:
- Article
Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 166, n. 3, p. 709, doi. 10.1007/s10549-017-4464-5
- By:
- Publication type:
- Article
Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial.
- Published in:
- Breast Cancer Research & Treatment, 2017, v. 161, n. 3, p. 473, doi. 10.1007/s10549-016-4075-6
- By:
- Publication type:
- Article
Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 1, p. 1, doi. 10.1007/s10549-016-3848-2
- By:
- Publication type:
- Article
Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 1, p. 45, doi. 10.1007/s10549-016-3739-6
- By:
- Publication type:
- Article
Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 1, p. 65, doi. 10.1007/s10549-015-3668-9
- By:
- Publication type:
- Article
A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 2, p. 441, doi. 10.1007/s10549-013-2573-3
- By:
- Publication type:
- Article
Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2011, v. 126, n. 2, p. 443, doi. 10.1007/s10549-010-1332-y
- By:
- Publication type:
- Article
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
- Published in:
- Histopathology, 2011, v. 59, n. 4, p. 776, doi. 10.1111/j.1365-2559.2011.03884.x
- By:
- Publication type:
- Article
Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
- Published in:
- Histopathology, 2011, v. 58, n. 4, p. 608, doi. 10.1111/j.1365-2559.2011.03781.x
- By:
- Publication type:
- Article
Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer.
- Published in:
- Diagnostic Pathology, 2011, v. 6, n. 1, p. 36, doi. 10.1186/1746-1596-6-36
- By:
- Publication type:
- Article
Mucocele-like lesions of the breast: a long-term follow-up study.
- Published in:
- Diagnostic Pathology, 2011, v. 6, n. 1, p. 29, doi. 10.1186/1746-1596-6-29
- By:
- Publication type:
- Article
Efficacy and safety of ixabepilone in taxane-resistant patients with metastatic breast cancer previously treated with anthracyclines: results of a phase II study in Japan.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1427, doi. 10.1007/s00280-013-2140-y
- By:
- Publication type:
- Article
Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast.
- Published in:
- Cancer Science, 2014, v. 105, n. 11, p. 1503, doi. 10.1111/cas.12535
- By:
- Publication type:
- Article
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancer.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 1, p. 31, doi. 10.1007/s12282-023-01509-7
- By:
- Publication type:
- Article
Interleukin (IL)-17A in triple-negative breast cancer: a potent prognostic factor associated with intratumoral neutrophil infiltration.
- Published in:
- Breast Cancer (13406868), 2023, v. 30, n. 5, p. 748, doi. 10.1007/s12282-023-01467-0
- By:
- Publication type:
- Article
Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 2, p. 335, doi. 10.1007/s12282-020-01162-4
- By:
- Publication type:
- Article
Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 5, p. 637, doi. 10.1007/s12282-019-00970-7
- By:
- Publication type:
- Article
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.
- Published in:
- Breast Cancer (13406868), 2014, v. 21, n. 6, p. 703, doi. 10.1007/s12282-013-0444-8
- By:
- Publication type:
- Article
Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
- Published in:
- Breast Cancer (13406868), 2013, v. 20, n. 2, p. 181, doi. 10.1007/s12282-011-0324-z
- By:
- Publication type:
- Article
The relevance of intrinsic subtype to clinicopathological features and prognosis in 4,266 Japanese women with breast cancer.
- Published in:
- Breast Cancer (13406868), 2011, v. 18, n. 4, p. 292, doi. 10.1007/s12282-010-0209-6
- By:
- Publication type:
- Article
Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2010, v. 17, n. 3, p. 212, doi. 10.1007/s12282-009-0135-7
- By:
- Publication type:
- Article
Clear cell hidradenoma of the breast: a case report with review of the literature.
- Published in:
- Breast Cancer (13406868), 2007, v. 14, n. 3, p. 307, doi. 10.2325/jbcs.14.307
- By:
- Publication type:
- Article
Rim enhancement of breast cancers on contrast-enhanced MR imaging: Relationship with prognostic factors.
- Published in:
- Breast Cancer (13406868), 2006, v. 13, n. 1, p. 64, doi. 10.2325/jbcs.13.64
- By:
- Publication type:
- Article